Cargando…

Clinical Features and Prognostic Factor of Thoracic Postoperative Oligo-Recurrence of Non-Small-Cell Lung Cancer

OBJECTIVE: The study aimed to clarify clinical features and prognostic factors of thoracic oligo-postoperative recurrences that underwent local therapy of non-small-cell lung cancer (NSCLC). METHODS: From 2332 patients of resected pathological stage I–IIIA NSCLC between 2008 and 2015, a total of 542...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Qi, Wang, Wei, Zhang, Qian, Wang, Yuchao, Chi, Chuanzhen, Xu, Chunhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049276/ https://www.ncbi.nlm.nih.gov/pubmed/32158271 http://dx.doi.org/10.2147/CMAR.S230579

Ejemplares similares

Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2019)

Prognostic significance of serum osteopontin levels in small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer
por: Li, Wen-Cai, et al.
Publicado: (2021)

Usefulness of virtual bronchoscopic navigation combined with endobronchial ultrasound guided transbronchial lung biopsy for solitary pulmonary nodules
por: Xu, Chunhua, et al.
Publicado: (2019)

Oligometastases/Oligo-Recurrence of Lung Cancer
por: Niibe, Yuzuru, et al.
Publicado: (2013)

Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis
por: Lin, Qingren, et al.
Publicado: (2021)

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer
por: Xu, Li-Ming, et al.
Publicado: (2017)

Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013)

A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
por: Patel, Pretesh R., et al.
Publicado: (2012)

The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer
por: Kang, Minsang, et al.
Publicado: (2023)

Evaluating the diagnostic and prognostic value of serum TuM2‐PK, NSE, and ProGRP in small cell lung cancer
por: Li, Li, et al.
Publicado: (2023)

Survival and Prognostic Factors for Breast Cancer Patients with Regional Oligo-Recurrence
por: Baek, Jong Yun, et al.
Publicado: (2020)

Commentary: The Prognostic Value of Oligo-Recurrence Following Esophagectomy for Esophageal Cancer
por: Mine, Shinji
Publicado: (2023)

Computed tomography-guided percutaneous transthoracic needle biopsy for solitary pulmonary nodules in diameter less than 20 mm
por: Xu, Chunhua, et al.
Publicado: (2018)

The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Li, Qi, et al.
Publicado: (2023)

Radial EBUS versus CT-guided needle biopsy for evaluation of solitary pulmonary nodules
por: Wang, Wei, et al.
Publicado: (2018)

Salvage radiotherapy for regional lymph node oligo‐recurrence after radical surgery of non‐small cell lung cancer
por: Seol, Ki Ho, et al.
Publicado: (2017)

Nanoparticle Albumin Bound Paclitaxel in the Third-Line Treatment of Recurrent Small Cell Lung Cancer in Real-World Practice: A Single Center Experience
por: Wang, Yuchao, et al.
Publicado: (2021)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy
por: Ma, Li, et al.
Publicado: (2017)

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors
por: Cha, Yu Jin, et al.
Publicado: (2017)

Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation
por: Nardone, Valerio, et al.
Publicado: (2016)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
por: Inoue, Tetsuya, et al.
Publicado: (2012)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016)

Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
por: Niibe, Yuzuru, et al.
Publicado: (2012)

Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer
por: Tabata, Ken-ichi, et al.
Publicado: (2012)

Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
por: Niibe, Yuzuru, et al.
Publicado: (2010)

Oligometastasis and oligo-recurrence: more than a mirage
por: Huang, Fang, et al.
Publicado: (2014)

Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer
por: Kanou, Takashi, et al.
Publicado: (2015)

Prognostic Impact of EBUS TBNA for Lung Adenocarcinoma Patients with Postoperative Recurrences
por: Chen, Ying-Yi, et al.
Publicado: (2022)

Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients
por: Aoki, Shuri, et al.
Publicado: (2020)

Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
por: Jiang, Kuikui, et al.
Publicado: (2023)

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Salvage radiotherapy for second oligo-recurrence in patients with breast cancer
por: Miyata, Mari, et al.
Publicado: (2018)

Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study
por: Takahashi, Wataru, et al.
Publicado: (2014)

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease
por: Zeng, Ya, et al.
Publicado: (2020)

Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With ALK-Rearranged Non-Small Cell Lung Cancer
por: Wang, Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8u6anjmpg66636f61pahr0m3ld